Entity
  • Viridian Therapeutics, Inc.

    Created in 2007
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    743 780 10,303
  • Activities

  • Technologies

  • Entity types

  • Location

    203 Crescent St 17 102b, Waltham, MA 02453, USA

    Waltham

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 158

  • Engaged corporates

    2
    1 2
  • Added in Motherbase

    5 years, 6 months ago
Description
  • Value proposition

    Framing the future of autoimmune diseases

    Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.

    Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is to advance VRDN-001 as a potential best-in-class intravenous therapy followed by VRDN-003 as a potential first- and best-in-class subcutaneous therapy for the treatment of TED.

    In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.

  • Viridian - Framing the future of autoimmune diseases

    Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions

  • https://www.viridiantherapeutics.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

1 May 2018


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Not capitalistic
Not partnership
Event

25 Jul 2017

31 Jul 2022



Similar entities
Loading...
Loading...
Social network dynamics